BC
TMCI icon

Birchview Capital’s Treace Medical Concepts TMCI Stock Holding History

Birchview Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-226,947
Closed -$556K – 81
2025
Q4 		$556K Buy
226,947
+50,000
+28% +$217K 0.33% 51
2025
Q3 		$1.19M Hold
176,947
– – 0.9% 31
2025
Q2 		$1.04M Buy
176,947
+12,000
+7% +$78.2K 1.03% 26
2025
Q1 		$1.38M Buy
164,947
+3,597
+2% +$32.3K 1.2% 22
2024
Q4 		$1.2M Buy
161,350
+93,000
+136% +$622K 0.98% 23
2024
Q3 		$396K Buy
+68,350
New +$439K 0.34% 33

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Birchview Capital's TMCI Position: Q1 2026 in Review

Birchview Capital sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 226,947 shares — an estimated $556K sold.

Birchview Capital first reported a position in TMCI in Q3 2024 and held it in 6 quarters. The position peaked at $1.38M in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Birchview Capital reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Birchview Capital sold 226,947 Treace Medical Concepts shares in Q1 2026, an estimated $556K.
  • Birchview Capital first reported a position in Treace Medical Concepts in Q3 2024 and held it in 6 quarters.
  • Birchview Capital's Treace Medical Concepts position peaked at $1.38M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Birchview Capital's 13F filing for Q1 2026, filed 15 May 2026.